In the US, Aclasta (zoledronic acid systemic) is a member of the drug class bisphosphonates and is used to treat Hypercalcemia of Malignancy, Osteolytic Bone Lesions of Multiple Myeloma, Osteolytic Bone Metastases of Solid Tumors, Osteoporosis and Paget's Disease.
Ingredient matches for Aclasta
Alendronic Acid is reported as an ingredient of Aclasta in the following countries:
Zoledronic Acid is reported as an ingredient of Aclasta in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)
- Hong Kong
- New Zealand
- South Africa
Zoledronic Acid monohydrate (a derivative of Zoledronic Acid) is reported as an ingredient of Aclasta in the following countries:
- Czech Republic
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.